China National Accord Medicines (SZSE:000028) Earnings per Share (Diluted)

: ¥2.95 (TTM As of Jun. 2023)

View and export this data going back to 1993. Start your Free Trial

China National Accord Medicines's Earnings per Share (Diluted) for the three months ended in Jun. 2023 was ¥0.84. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was ¥2.95.

China National Accord Medicines's EPS (Basic) for the three months ended in Jun. 2023 was ¥0.84. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2023 was ¥2.95.

China National Accord Medicines's EPS without NRI for the three months ended in Jun. 2023 was ¥0.84. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2023 was ¥2.95.

During the past 12 months, China National Accord Medicines's average EPS without NRIGrowth Rate was 29.40% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 5.40% per year. During the past 5 years, the average EPS without NRI Growth Rate was 6.20% per year. During the past 10 years, the average EPS without NRI Growth Rate was 7.70% per year.

During the past 13 years, China National Accord Medicines's highest 3-Year average EPS without NRI Growth Rate was 94.10% per year. The lowest was -38.20% per year. And the median was 15.70% per year.

China National Accord Medicines Earnings per Share (Diluted) Historical Data

The historical data trend for China National Accord Medicines's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China National Accord Medicines Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Earnings per Share (Diluted)

2.18

2.28

2.52

2.40

2.67

China National Accord Medicines Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Earnings per Share (Diluted)																0.76	0.68	0.79	0.65	0.84

Competitive Comparison

For the Medical Distribution subindustry, China National Accord Medicines's Earnings per Share (Diluted), along with its competitors' market caps and Earnings per Share (Diluted) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Annual Data Quarterly Data

China National Accord Medicines Earnings per Share (Diluted) Distribution

For the Medical Distribution industry and Healthcare sector, China National Accord Medicines's Earnings per Share (Diluted) distribution charts can be found below:

* The bar in red indicates where China National Accord Medicines's Earnings per Share (Diluted) falls in comparison to its industry or sector. The grey bar indicates the Earnings per Share (Diluted)'s extreme value range as defined by GuruFocus.

China National Accord Medicines Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

China National Accord Medicines's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2022 is calculated as

Diluted Earnings Per Share (A: Dec. 2022 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(1486.708	-	0)	/	556.980
	=	2.67

China National Accord Medicines's Earnings Per Share (Diluted) for the quarter that ended in Jun. 2023 is calculated as

Diluted Earnings Per Share (Q: Jun. 2023 )	=	(Net Income	-	Preferred Dividends	/	Shares Outstanding (Diluted Average)
	=	(468.046	-	0)	/	560.470
	=	0.84

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2.95

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.

China National Accord Medicines (SZSE:000028) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

China National Accord Medicines Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of China National Accord Medicines's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

China National Accord Medicines (SZSE:000028) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China National Accord Medicines Corp Ltd (SZSE:000028) » Definitions » Earnings per Share (Diluted)

Traded in Other Exchanges

200028:China

Address

No. 15, Ba Gua Si 4th Road, Accord Pharmaceutical Building, Futian District, Guangdong Province, Shenzhen, CHN, 518029

Website

http://www.szaccord.com.cn

China National Accord Medicines Corp Ltd develops and manufactures pharmaceuticals in China. The company engaged in the wholesale of Chinese patent drugs, traditional Chinese medicines, chemical medicine preparations, antibiotics, biochemical drugs and cerebrovascular system drugs. It operates through the following segments: The Head office segment engages in investing and managing the business; The Pharmaceutical Distribution segment engages in the distribution of medicine and pharmaceutical products to customers, including hospitals, other distributors, retail drug stores, and clinics, and Retail pharmacy segment, which is managing the operation of Guoda Pharmacy. It generates maximum revenue from the Pharmaceutical Distribution segment.

China National Accord Medicines (SZSE:000028) Headlines

No Headlines